
Toyochem Pharma (Bombay) Private Limited
About Toyochem Pharma (Bombay) Private Limited
Data last updated:
Toyochem Pharma (Bombay) Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1995PTC088995.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.7 Lakh. It is led by directors including Mayank Jashwantlal Shah and Shruti Mayank Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Aidun Bldg 5th Floor Ist Dhobi Talao, Mumbai, Maharashtra, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹69.21 Lakh (net margin 62.2%) and EBITDA of ₹94.79 Lakh (EBITDA margin 85.2%). Revenue has grown at a compounded annual rate (CAGR) of 177% over three years and 86% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Toyochem Pharma (Bombay) Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressAidun Bldg 5th Floor Ist Dhobi Talao, Mumbai, Maharashtra, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Toyochem Pharma (Bombay) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Toyochem Pharma (Bombay) Private Limited
FY 2025 filings availableToyochem Pharma (Bombay) Private Limited reported revenue of ₹1.11 Cr (up 1526% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 86% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹94.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹69.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 85.2% | ||||
| Net Profit Margin | 62.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Toyochem Pharma (Bombay) Private Limited, buy the company report.
Board of directors of Toyochem Pharma (Bombay) Private Limited
Toyochem Pharma (Bombay) has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mayank Jashwantlal Shah Also directs: Mauli Hotel Ventures LLP, Homesphere Lifestyle LLP, Gajendra Investment Limited and 5 more | Director | 06 Jan 2017 | 9 Years 10 Months | Current |
| Shruti Mayank Shah Also directs: Kepl Leisure Limited Liability Partnership, Mauli Hotel Ventures LLP, Homesphere Lifestyle LLP and 1 more | Director | 31 May 1995 | 31 Years 5 Months | Current |
| Shreyans Jaswantlal Shah Also directs: Gajendra Investment Limited, Vidhi Research & Development LLP, MJ Shah Realtors LLP and 4 more | Director | 31 May 1995 | 31 Years 5 Months | Current |
Peer comparison
Toyochem Pharma (Bombay) Private Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Toyochem Pharma (Bombay) Private Limitedthis company | ₹1.11 Cr (FY 2025) | ₹69.21 Lakh | 62.2% | 1526.0% | Mumbai, Maharashtra, India | |
| Devsons Meditex Private Limited | ₹1.11 Cr (FY 2025) | 11.0% | Agra, Uttar Pradesh, India | |||
| Advance Zircon Private Limited | ₹1.11 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Dr. Ars India Labs Private Limited | ₹1.11 Cr (FY 2025) | -1.0% | Madurai, Tamil Nadu, India |
To see the full peer comparison of Toyochem Pharma (Bombay) Private Limited, buy the company report.
Auditor
Toyochem Pharma (Bombay) Private Limited is audited by Vijay R. Tater & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vijay R. Tater & Co. | FY 2022 | 111426W |
Shareholding
The shareholding of Toyochem Pharma (Bombay) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Toyochem Pharma (Bombay) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Toyochem Pharma (Bombay) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Toyochem Pharma (Bombay) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Toyochem Pharma (Bombay) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Toyochem Pharma (Bombay) Private Limited has 5 board changes on record since 1995: 4 appointments and 1 cessation. The latest: Mayank Jashwantlal Shah was appointed as Director on 06 Jan 2017.
Frequently asked questions
Toyochem Pharma (Bombay) is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 May 1995 (31+ years old) and is registered under CIN U24230MH1995PTC088995.
Toyochem Pharma (Bombay) has 3 current directors:
- Mayank Jashwantlal Shah - Director
- Shruti Mayank Shah - Director
- Shreyans Jaswantlal Shah - Director
The latest financial statements of Toyochem Pharma (Bombay) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Toyochem Pharma (Bombay) is U24230MH1995PTC088995. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Toyochem Pharma (Bombay) was incorporated on 31 May 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Toyochem Pharma (Bombay) by revenue are Devsons Meditex Private Limited, Advance Zircon Private Limited, Dr. Ars India Labs Private Limited, all in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mayank Jashwantlal Shah was appointed as Director on 06 Jan 2017. Mangalaben Jashwantlal Shah ceased to be Director on 20 Nov 2013. Mangalaben Jashwantlal Shah was appointed as Director on 31 May 1995. Toyochem Pharma (Bombay) has 5 board changes on record in total.
The registered office of Toyochem Pharma (Bombay) is at Aidun Bldg 5th Floor Ist Dhobi Talao, Mumbai, Maharashtra, India.
Toyochem Pharma (Bombay) operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Toyochem Pharma (Bombay) is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.
Toyochem Pharma (Bombay) can be reached at its registered office: Aidun Bldg 5th Floor Ist Dhobi Talao, Mumbai, Maharashtra, India.

